Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide

Nature Clinical Practice. Gastroenterology & Hepatology
P Jay PasrichaJ Jankovic

Abstract

Metoclopramide, the only drug approved by the FDA for treatment of diabetic gastroparesis, but used off-label for a variety of other gastrointestinal indications, has many potentially troublesome adverse neurologic effects, particularly movement disorders. In this article, we comprehensively review the indications and side effects of metoclopramide, and describe some common pitfalls and strategies to minimize the medicolegal risks to the prescribing physician. Metoclopramide accounts for nearly a third of all drug-induced movement disorders, a common reason for a malpractice suit. The entire spectrum of drug-induced movement disorders, ranging from subtle to life-threatening, can ensue from its use; akathisia and dystonia are generally seen early in the course of metoclopramide-induced movement disorders, whereas tardive dyskinesia and parkinsonism seem to be more prevalent in chronic users. Female sex, age and diabetes are the major risk factors for metoclopramide-induced movement disorders. It is therefore incumbent on gastroenterologists and other prescribing physicians to become familiar with the adverse neurologic effects associated with the use of metoclopramide, and to take appropriate preventive and defensive measures.

References

Dec 1, 1992·Clinical Neuropharmacology·J M KernsP M Carvey
Jan 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·R Macpherson, R Collis
Jul 1, 1992·The Annals of Pharmacotherapy·R B StewartW E Hale
Jan 1, 1992·Movement Disorders : Official Journal of the Movement Disorder Society·I J MitchellL M Gunne
Jan 1, 1991·Movement Disorders : Official Journal of the Movement Disorder Society·A S WaltersS Chokroverty
May 1, 1990·Southern Medical Journal·L G Miller, J Jankovic
Apr 1, 1991·Clinical Neuropharmacology·S Giménez-Roldán, D Mateo
Jun 1, 1991·Diseases of the Colon and Rectum·J D CheapeD G Jagelman
Oct 1, 1989·Archives of General Psychiatry·J A LiebermanJ M Kane
Aug 1, 1988·The American Journal of Psychiatry·G W AranaG A Keepers
Jun 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·R J Hardie, A J Lees
Aug 1, 1988·Journal of Clinical Psychopharmacology·P Seeman
Feb 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·W M GlazerJ Hughes
Sep 1, 1988·The Journal of Nervous and Mental Disease·J N HerreraB N Nguyen
Oct 1, 1986·The British Journal of Radiology·D J Morewood, G H Whitehouse
Oct 5, 1985·British Medical Journal·D N BatemanJ M Simpson
Apr 1, 1985·The American Journal of Psychiatry·R E Drake, J Ehrlich
Apr 1, 1982·Archives of General Psychiatry·J M Kane, J M Smith
Oct 1, 1982·Archives of Neurology·A H RajputP Seeman
Jan 1, 1984·Clinical Neuropharmacology·H L KlawansA Barr
Nov 1, 1984·JPEN. Journal of Parenteral and Enteral Nutrition·K WhatleyM Guthrie
Jun 1, 1981·Annals of Internal Medicine·W M BattleR Tuthill
Dec 13, 1995·JAMA : the Journal of the American Medical Association·J AvornA Walker
Jun 1, 1995·Diseases of the Colon and Rectum·R W GolubP S Aguilar
Nov 1, 1994·Biological Psychiatry·D D SewellD V Jeste
Jan 1, 1993·Psychopharmacology·P Sachdev, C Loneragan
Mar 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·P F Buckley, M Hutchinson
Aug 1, 1994·Current Opinion in Neurology·J Kornhuber, M Weller
May 1, 1993·Annals of Neurology·C BurkhardtW D Parker
May 1, 1994·The American Journal of Emergency Medicine·E J ScharmanE P Krenzelok
Jun 1, 1995·Clinical Neuropharmacology·J Jankovic
Feb 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·V BocolaN Martucci

❮ Previous
Next ❯

Citations

Nov 6, 2010·Pharmacy World & Science : PWS·Arthur R Van GoolCaroline Seynaeve
Jun 13, 2012·Current Gastroenterology Reports·Reza A HejaziIrene Sarosiek
Aug 1, 2010·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Uazman AlamRayaz Ahmed Malik
Jul 20, 2011·Nature Reviews. Gastroenterology & Hepatology·William L Hasler
Jan 9, 2013·Nature Reviews. Gastroenterology & Hepatology·Eamonn M M Quigley, Brian E Lacy
Jul 27, 2007·The New England Journal of Medicine·Robert J Heine, Robert Brodows
Dec 17, 2009·Nursing Research·Norma A MethenyBarbara J Stewart
May 30, 2013·BMC Psychiatry·Ray M MerrillPaul M Matiaco
Mar 5, 2011·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Badr M Aljarallah
Jan 1, 2012·Scientifica·Klaus Bielefeldt
Dec 7, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Leslie J CloudStewart A Factor
Oct 25, 2014·Expert Opinion on Investigational Drugs·Kenneth Barshop, Braden Kuo
Sep 13, 2011·Psychosomatics·Robert J Surawski, Davin K Quinn
Jun 27, 2009·The American Journal of Emergency Medicine·Linda A ReganLewis S Nelson
Oct 18, 2008·Journal of Perianesthesia Nursing : Official Journal of the American Society of PeriAnesthesia Nurses·Daniel D Moos, Debra J Hansen
Feb 9, 2008·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·G J Sanger, D H Alpers
Jan 29, 2008·Journal of Clinical Pharmacology·Christopher KenneyJoseph Jankovic
Jan 8, 2008·Alimentary Pharmacology & Therapeutics·J J L Haans, A A M Masclee
Nov 13, 2007·Acta Neurologica Scandinavica·S A ZivkovićK M Abu-Elmagd
Apr 5, 2013·The European Journal of Neuroscience·Souha MahmoudiDaniel Lévesque
Jun 14, 2013·Emergency Medicine Australasia : EMA·Diana Egerton-Warburton, Kirsty Povey
Apr 23, 2014·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J BroadG J Sanger
Nov 6, 2009·Alimentary Pharmacology & Therapeutics·A S Rao, M Camilleri
Aug 3, 2010·Parkinsonism & Related Disorders·Raja Mehanna, Joseph Jankovic
Apr 19, 2016·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Asli TufanMehmet Akif Karan
May 15, 2013·Expert Opinion on Pharmacotherapy·Julie E StevensMichael Horowitz
Apr 17, 2015·European Journal of Clinical Pharmacology·Jila AgahAbolfazl Rad
Apr 1, 2016·Expert Opinion on Drug Safety·Richard McCallumMohammad Bashashati
May 27, 2009·Journal of the Neurological Sciences·Hyeo-Il MaByung-Chul Lee
Nov 26, 2014·Nature Reviews. Endocrinology·Liza K PhillipsMichael Horowitz
Aug 13, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Jiaxing TianXiaolin Tong
Jan 28, 2017·Expert Opinion on Investigational Drugs·Gareth J Sanger, Pankaj Jay Pasricha
Feb 20, 2010·Journal of Diabetes Science and Technology·Lawrence A Szarka, Michael Camilleri
Nov 22, 2017·Scandinavian Journal of Gastroenterology·Per M Hellström, Ahmad Al-Saffar
Dec 11, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Christine D Esper, Stewart A Factor
Feb 5, 2009·Expert Opinion on Pharmacotherapy·Savio C Reddymasu, Richard W McCallum
Nov 26, 2009·Expert Opinion on Pharmacotherapy·Alfonso Fasano, Anna Rita Bentivoglio

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.